Key Takeaways
The pandemic has accelerated adoption and growth of virtual and hybrid care models, with 2020 on track to attract a record $16B, far outpacing the $12.1B+ raised in 2019.
01 HealthTech has raised $12B+ through Q3 2020
The first three quarters of 2020 have already set an annual record for healthtech funding.
02 Alternative care leaps ahead during the COVID-19 pandemic
In 2020, alternative care has accounted for 38% ($4B+) of venture-backed healthtech funding.
03 16% of the US may be adversely affected by mental health in 2021
Mental health has seen increased investor activity, with startups projected to raise $1B+ in 2020.
HealthTech funding to reach $16B+ in 2020
Over the last four years, private venture-backed healthtech companies have seen $1B+ in global* financings quarter over quarter. This year, US companies have raised a staggering 82% of global funding; Europe and China contribute 10% and 8%, respectively.
Alternative care has raised $4B+ in 2020
Alternative care companies pave the way in terms of subsector funding, surpassing the next highest-funded subsector (provider operations) by an incredible $2.6B over the last three years.
Virtual and hybrid care take center stage
Historically, alternative care companies have skewed toward providing virtual care or in-person care; however, due to wide-spread adoption of telehealth during the COVID-19 pandemic, in-person companies have adopted a virtual care component, creating a hybrid care model.
Mental health funding may cross $1B+ in 2020
Mental health funding is on an upward trend this year, with the most active investors favoring later-stage mental health companies. 1H 2020’s unprecedented funding can be attributed to three $90M+ deals.
SVB’s strong HealthTech index performance due to virtual care
In 2020, the SVB Global HealthTech Index (+102%) has recovered faster than the DJIA (-4%), S&P 500 (+2%) and Nasdaq (+14%). It is also ahead of FAMGA (+42%), whose companies have been relatively resilient to the pandemic.
Explore other Healthcare reports
Written and researched by SVB experts
Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank.
